The aim of this study was to test whether the serum levels of fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) could be used as a diagnostic tool for NASH. The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatohepatitis.